UN High-Level Meeting on antimicrobials—what do we need?

The Lancet

Volumn 388, Issue 10041, 2016, Pages 218-220

  Laxminarayan, Ramanan ^a,b,c   Amábile Cuevas, Carlos F ^d   Cars, Otto ^e   Evans, Timothy ^f   Heymann, David L ^g   Hoffman, Steven ^h   Holmes, Alison ⁱ   Mendelson, Marc ^j   Sridhar, Devi ^k   Woolhouse, Mark ^k   Røttingen, John Arne ^l,m,n  

^a DC   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^d Fundacion LUSARA   (Mexico)

^e UPPSALA UNIVERSITY   (Sweden)

^f WORLD BANK   (United States)

^g ROYAL INSTITUTE OF INTERNATIONAL AFFAIRS   (United Kingdom)

^h UNIVERSITY OF OTTAWA   (Canada)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^m UNIVERSITY OF OSLO   (Norway)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VACCINE;

AGRICULTURE; ANIMAL HUSBANDRY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; DRUG EFFICACY; DRUG USE; ENVIRONMENT; FINANCIAL MANAGEMENT; HEALTH; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; LOWEST INCOME GROUP; MIDDLE INCOME COUNTRY; NEWBORN SEPSIS; NOTE; PRIORITY JOURNAL; SUSTAINABLE DEVELOPMENT; UNITED NATIONS; WORLD HEALTH ORGANIZATION; BACTERIAL INFECTIONS;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS; UNITED NATIONS;

EID: 84982155987     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)31079-0     Document Type: Note

References (9)

1. 1 Laxminarayan, R, Duse, A, Wattal, C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis 13 (2013), 1057–1098.
2. 2 O'Neill, J, Tackling drug-resistant infections globally: final report and recommendations, 2016, H M Government/Wellcome Trust, London.
3. 3 Laxminarayan, R, Matsoso, P, Pant, S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet 387 (2016), 168–175.
4. 4 Jasovsky, D, Littmann, J, Zorzet, A, Cars, O, Antimicrobial resistance—a threat to the world's sustainable development. Upsala J Med Sci 121 (2016), 159–164.
5. 5 Ardal, C, Outterson, K, Hoffman, SJ, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet 387 (2016), 296–307.
6. 6 WHO. Global action plan on antimicrobial resistance, 2015, World Health Organization, Geneva.
7. 7 Mendelson, M, Røttingen, JA, Gopinathan, U, et al. Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries. Lancet 387 (2016), 188–198.
8. 8 Heymann, DL, What to do about antimicrobial resistance. BMJ, 353, 2016, i3087.
9. 9 Woolhouse, M, Ward, M, van Bunnik, B, Farrar, J, Antimicrobial resistance in humans, livestock and the wider environment. Philos Trans R Soc Lond B Biol Sci, 370, 2015, 20140083.